These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 19641887)

  • 1. Studies on the formation of hydrophobic ion-pairing complex of alendronate.
    You SK; Kwon HH; Lee JM; Shin SC; Cho CW
    Arch Pharm Res; 2009 Jul; 32(7):1055-60. PubMed ID: 19641887
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alendronate-loaded microparticles for improvement of intestinal cellular absorption.
    Baek JS; Kwon HH; Hwang JS; Sung HC; Lee JM; Shin SC; Kim YR; Cho CW
    J Drug Target; 2011 Jan; 19(1):37-48. PubMed ID: 20477555
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High payload nanostructured lipid carriers fabricated with alendronate/polyethyleneimine ion complexes.
    Abd El-Hamid BN; Swarnakar NK; Soliman GM; Attia MA; Pauletti GM
    Int J Pharm; 2018 Jan; 535(1-2):148-156. PubMed ID: 29104057
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enteric-coated alendronate sodium nanoliposomes: a novel formula to overcome barriers for the treatment of osteoporosis.
    Hosny KM; Ahmed OA; Al-Abdali RT
    Expert Opin Drug Deliv; 2013 Jun; 10(6):741-6. PubMed ID: 23656470
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Process analytical technology to understand the disintegration behavior of alendronate sodium tablets.
    Xu X; Gupta A; Sayeed VA; Khan MA
    J Pharm Sci; 2013 May; 102(5):1513-23. PubMed ID: 23450666
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Electrospray tandem mass spectrometry of alendronate analogues: fingerprints for characterization of new potential prodrugs.
    Hardouin J; Guénin E; Malosse C; Caron M; Lecouvey M
    Rapid Commun Mass Spectrom; 2008 Aug; 22(15):2287-300. PubMed ID: 18613280
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hydrophobic ion pairing of isoniazid using a prodrug approach.
    Zhou H; Lengsfeld C; Claffey DJ; Ruth JA; Hybertson B; Randolph TW; Ng KY; Manning MC
    J Pharm Sci; 2002 Jun; 91(6):1502-11. PubMed ID: 12115849
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dental enamel dissolution after alendronate treatment.
    Gandolfi MG; Nucci C; Prati C; Mongiorgi R
    Am J Dent; 2007 Aug; 20(4):235-40. PubMed ID: 17907486
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibacterial activity of quaternary ammonium chitosan containing mono or disaccharide moieties: preparation and characterization.
    Sajomsang W; Gonil P; Tantayanon S
    Int J Biol Macromol; 2009 Jun; 44(5):419-27. PubMed ID: 19428476
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inherent anchorages in UiO-66 nanoparticles for efficient capture of alendronate and its mediated release.
    Zhu X; Gu J; Wang Y; Li B; Li Y; Zhao W; Shi J
    Chem Commun (Camb); 2014 Aug; 50(63):8779-82. PubMed ID: 24967656
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assembly of a model hydrophobic drug into cationic bilayer fragments.
    Vieira DB; Pacheco LF; Carmona-Ribeiro AM
    J Colloid Interface Sci; 2006 Jan; 293(1):240-7. PubMed ID: 16095603
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Conjugation of poorly absorptive drugs with mucoadhesive polymers for the improvement of oral absorption of drugs.
    Sakuma S; Matsumoto T; Yamashita S; Wang Y; Lu ZR
    J Control Release; 2007 Nov; 123(3):195-202. PubMed ID: 17888541
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Theoretical investigation of passive intestinal membrane permeability using Monte Carlo method to generate drug-like molecule population.
    Sugano K
    Int J Pharm; 2009 May; 373(1-2):55-61. PubMed ID: 19429288
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stability of fenbendazole suspensions for veterinary use. Correlation between zeta potential and sedimentation.
    Arias JL; López-Viota M; Clares B; Ruiz MA
    Eur J Pharm Sci; 2008 Aug; 34(4-5):257-62. PubMed ID: 18539013
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alendronate sodium.
    Ananchenko G; Novakovic J; Tikhomirova A
    Profiles Drug Subst Excip Relat Methodol; 2013; 38():1-33. PubMed ID: 23668401
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The absorption of (99m)Tc-alendronate given by rectal route in rabbits.
    Asikoğlu M; Ozguney I; Ozcan I; Orumlu O; Guneri T; Koseoğlu K; Ozkilic H
    Pharm Dev Technol; 2008; 13(3):213-20. PubMed ID: 18484490
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis of 3,5-diaryl substituted indole derivatives and its selective iodide ion chemosensing.
    Rathikrishnan KR; Indirapriyadharshini VK; Ramakrishna S; Murugan R
    Spectrochim Acta A Mol Biomol Spectrosc; 2012 Feb; 86():640-4. PubMed ID: 22119122
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An investigation into the ability of alendronate ion pairs to increase oral absorption.
    Samiei N; Foroutan SM; Razipour F; Zarghi A; Shafaati A
    Int J Pharm; 2017 Jul; 527(1-2):184-190. PubMed ID: 28552769
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative in vitro study of oesophageal adhesiveness of different commercial formulations containing alendronate.
    Shakweh M; Bravo-Osuna I; Ponchel G
    Eur J Pharm Sci; 2007 Aug; 31(5):262-70. PubMed ID: 17576054
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Possibilities for the in vitro evaluation of bioavailability. 5. Compact peroral agents with basic drugs].
    Fürst W; Neubert R; Bendas C; Lärm M; König A
    Pharmazie; 1987 Jul; 42(7):458-60. PubMed ID: 3671472
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.